Domestic Pharma Growth Strong, US Market Drag to Weigh on Q4FY26 Earnings: Report sheeba farhat10 April 2026 9:01 PM ISTNew Delhi: India's pharmaceutical sector is likely to witness steady domestic growth but continued pressure in the US market in the fourth quarter of...
JB Chemicals Appoints Aman Mehta as MD, Expands Board with Three New Directors Parthika Patel26 March 2026 11:47 PM ISTMumbai: J.B. Chemicals & Pharmaceuticals Limited has announced key changes to its board following shareholder approval via postal ballot,...
State Drug Alert: From Antibiotics to Antihypertensives, 134 Samples Found NSQ in February Audit Susmita Roy25 March 2026 11:36 PM ISTNew Delhi: Reflecting ongoing concerns over drug quality in India, the Central Drugs Standard Control Organisation (CDSCO) has flagged 134 drug...
Wockhardt's Nafithromycin 400 mg May Get 5-Year Price Control Exemption Susmita Roy8 March 2026 1:00 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) Multidisciplinary Committee (MDC) has recommended granting exemption from price...
CDSCO Clears AstraZeneca's Imfinzi (Durvalumab) for Additional Cancer Indication in India Farhat Nasim10 Feb 2026 8:10 PM ISTNew Delhi: AstraZeneca Pharma India Ltd on Tuesday said it has received permission from India's drug regulator to market Durvalumab solution for...
CDSCO Panel Flags Ethnic Variability, Seeks More Data from Takeda for Fruquintinib Hard Capsule Approval Susmita Roy3 Feb 2026 1:45 PM ISTNew Delhi: Following a detailed evaluation of global Phase III clinical data and safety findings of Fruquintinib 1 mg and 5 mg Hard capsule, the...
Sun Pharma's Dementia Drug Rivastigmine Banned in China sheeba farhat27 Jan 2026 2:27 PM ISTIn 2024, the USFDA issued a warning letter to Sun Pharma alleging "significant violations" of "current good manufacturing practice" regulations for...
Lupin Eyes Rs 11,800 Crore Vitabiotics Buyout, Lalvani Family-Owned Brand in Focus Farhat Nasim3 Dec 2025 6:13 PM ISTMumbai: Indian pharma major Lupin, alongside private-equity firms TPG Capital and EQT Partners, is reportedly in early-stage discussions to acquire...
Reliance Life Sciences Gets CDSCO Panel Nod for Phase I/III Trial of Biosimilar Nivolumab Parthika Patel14 Oct 2025 5:09 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has granted approval to Reliance Life...
30 Pharma Firms Under MPFDA, CDSCO Scanner in Madhya Pradesh Parthika Patel13 Oct 2025 9:48 PM ISTIndore: After the tragic deaths of several children allegedly linked to contaminated cough syrups in Chhindwara and Betul, Madhya Pradesh's...
CDSCO Flags 55 Substandard, 4 Spurious Drugs in June Batch Alert, Full List Inside Farhat Nasim19 July 2025 3:00 PM ISTNew Delhi: In its latest regulatory update for June 2025, the Central Drugs Standard Control Organisation (CDSCO) has flagged a total of 55 drug...
Govt Panel Proposes Braille Cards, Voice-Enabled QR Codes on Medicine Packs to Aid Visually Impaired Farhat Nasim6 July 2025 11:30 AM ISTNew Delhi: In a move aimed at improving accessibility for the visually impaired, the Drugs Consultative Committee (DCC) has recommended placing the...
